Australia · Delayed Price · Currency is AUD XRF Scientific Statistics
Total Valuation
XRF Scientific has a market cap or net worth of AUD 300.38 million. The enterprise value is 293.26 million.
| Market Cap | 300.38M |
| Enterprise Value | 293.26M |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | Sep 10, 2026 |
Share Statistics
XRF Scientific has 143.04 million shares outstanding. The number of shares has increased by 3.14% in one year.
| Current Share Class | 143.04M |
| Shares Outstanding | 143.04M |
| Shares Change (YoY) | +3.14% |
| Shares Change (QoQ) | +3.31% |
| Owned by Insiders (%) | 19.74% |
| Owned by Institutions (%) | 3.76% |
| Float | 102.18M |
Valuation Ratios
The trailing PE ratio is 28.77 and the forward PE ratio is 22.89.
| PE Ratio | 28.77 |
| Forward PE | 22.89 |
| PS Ratio | 4.58 |
| PB Ratio | 4.44 |
| P/TBV Ratio | 6.40 |
| P/FCF Ratio | 30.42 |
| P/OCF Ratio | 25.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.83, with an EV/FCF ratio of 29.69.
| EV / Earnings | 27.42 |
| EV / Sales | 4.46 |
| EV / EBITDA | 16.83 |
| EV / EBIT | 18.60 |
| EV / FCF | 29.69 |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.91 |
| Quick Ratio | 2.30 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.24 |
| Interest Coverage | 117.62 |
Financial Efficiency
Return on equity (ROE) is 16.57% and return on invested capital (ROIC) is 17.79%.
| Return on Equity (ROE) | 16.57% |
| Return on Assets (ROA) | 12.76% |
| Return on Invested Capital (ROIC) | 17.79% |
| Return on Capital Employed (ROCE) | 21.98% |
| Weighted Average Cost of Capital (WACC) | 7.75% |
| Revenue Per Employee | 1.34M |
| Profits Per Employee | 218,503 |
| Employee Count | 48 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, XRF Scientific has paid 4.88 million in taxes.
| Income Tax | 4.88M |
| Effective Tax Rate | 31.77% |
Stock Price Statistics
The stock price has increased by +6.30% in the last 52 weeks. The beta is 0.64, so XRF Scientific's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +6.30% |
| 50-Day Moving Average | 1.87 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 64.38 |
| Average Volume (20 Days) | 268,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XRF Scientific had revenue of AUD 64.40 million and earned 10.49 million in profits. Earnings per share was 0.07.
| Revenue | 64.40M |
| Gross Profit | 31.72M |
| Operating Income | 15.46M |
| Pretax Income | 15.37M |
| Net Income | 10.49M |
| EBITDA | 16.28M |
| EBIT | 15.46M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 9.46 million in cash and 2.34 million in debt, with a net cash position of 7.12 million or 0.05 per share.
| Cash & Cash Equivalents | 9.46M |
| Total Debt | 2.34M |
| Net Cash | 7.12M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 66.40M |
| Book Value Per Share | 0.46 |
| Working Capital | 32.61M |
Cash Flow
In the last 12 months, operating cash flow was 11.39 million and capital expenditures -1.70 million, giving a free cash flow of 9.69 million.
| Operating Cash Flow | 11.39M |
| Capital Expenditures | -1.70M |
| Depreciation & Amortization | 818,895 |
| Net Borrowing | -978,186 |
| Free Cash Flow | 9.69M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 49.26%, with operating and profit margins of 24.00% and 16.29%.
| Gross Margin | 49.26% |
| Operating Margin | 24.00% |
| Pretax Margin | 23.87% |
| Profit Margin | 16.29% |
| EBITDA Margin | 25.27% |
| EBIT Margin | 24.00% |
| FCF Margin | 15.04% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.14%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 2.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 8 |
| Payout Ratio | 47.83% |
| FCF Payout Ratio | 66.45% |
| Buyback Yield | -3.14% |
| Shareholder Yield | -0.96% |
| Earnings Yield | 3.48% |
| FCF Yield | 3.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for XRF Scientific is 2.31, which is 10.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2.31 |
| Price Target Difference | 10.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 13.68% |
| EPS Growth Forecast (3Y) | 15.56% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XRF Scientific has an Altman Z-Score of 16.35 and a Piotroski F-Score of 8.
| Altman Z-Score | 16.35 |
| Piotroski F-Score | 8 |